The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s peptide therapeutics market report forecasts the peptide therapeutics market size to grow to $58.75 Billion by 2027, with a CAGR (compound annual growth rate) of more than 9%.

Learn More On The Peptide Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Peptide Therapeutics Market Size Forecast
The global peptide therapeutics market is expected to grow from $37.26 billion in 2022 to $40.7 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The peptide therapeutics market size is expected to grow to $58.75 billion in 2027 at a CAGR of 9.6%.

North America held the largest peptide therapeutics market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Peptide Therapeutics Market Driver ­– Increase In The Prevalence Of Chronic Diseases
For instance, in 2020, according to the American Hospital Association (AHA), the national organization that represents and serves all types of hospitals and health care networks and their patients and communities, 157 million Americans were affected by chronic diseases in 2020, and it is estimated to reach 171 million by 2030. Therefore, the increase in the prevalence of chronic diseases is expected to drive the peptide therapeutics market during the forecast period.

Request for A Sample Of The Global Peptide Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

Key Peptide Therapeutics Market Trend – Technological Advancement
The companies operating in peptide therapeutics are utilizing advanced technologies such as artificial intelligence is to attain higher efficiency in drug development. For instance, in April 2020, Nuratis, an Ireland-based biotech company is utilizing artificial intelligence (AI) technologies to discover therapeutic peptides, extended its research into possible remedies for COVID-19 symptoms. Nuritas employed its AI platform to find peptides that are effective against COVID-19 targets. It took two initiatives to identify COVID-19 peptides: one for antiviral peptides that target how SARS-CoV-2 hijacks cells and the other for peptides that locally lower lung inflammation without inhibiting the immune system as a whole.

Peptide Therapeutics Market Segment
1) By Type: Generic, Branded
2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal
3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications

Peptide Therapeutics Market Major Players and Strategies
Major players in the peptide therapeutics market are Amgen, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Sanofi, AstraZeneca plc, Novartis AG, Teva Pharmaceutical Industries Ltd., Bachem Holding AG, Takeda Pharmaceutical Company Limited, Galena Biopharmaceuticals, Arch Biopartners, Arch Biopartners Inc., Novo Nordisk A/S, Circle Pharma Inc., and Corden Pharma GmbH.

In August 2021, Bayer, a Germany-based pharmaceutical company acquired Vividion Therapeutics for an undisclosed amount. Through this acquisition, Bayer will improve its small molecule expertise and reach new markets. The addition of a cutting-edge chemoproteomics platform will improve Bayer’s drug discovery capabilities. Vividion Therapeutics, Inc., is a US-based biotechnology company focused on transforming the future of human health by creating highly selective small-molecule medicines that drug traditionally inaccessible targets.

The Peptide Therapeutics Global Market Report 2023 covers regional data on peptide therapeutics market size, peptide therapeutics market trends and drivers, opportunities, strategies, and peptide therapeutics market competitor analysis. The countries covered in the peptide therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Peptide therapeutics refer to a therapeutic approach that uses peptides as medications. Peptides are a distinct family of pharmacological substances that are molecularly situated in between proteins and tiny molecules. Peptides that are found in nature serve a variety of purposes, including those of hormones, growth factors, neurotransmitters, ion channel ligands, and anti-infectives. Consequently, using peptides as treatments offers a way to target a variety of cells and control their response.

View More Reports Related To The Peptide Therapeutics Market –
Peptide Antibiotics Global Market Report 2023
Biosimilar Therapeutic Peptides Global Market Report 2023
Oral Biologics And Biosimilars Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: